FDA inspection
Shandong Anhong Pharmaceutical Co., Ltd.: FDA inspection ending Jun 26, 2026
FDA inspection 1328488 · Official Action Indicated (OAI) · Dezhou
Key facts
| Inspection ID | 1328488 |
|---|---|
| Firm | Shandong Anhong Pharmaceutical Co., Ltd. |
| FEI number | 3003877289 |
| City | Dezhou |
| Country | China |
| Fiscal year | 2026 |
| Inspection end date | Jun 26, 2026 |
| Classification | Official Action Indicated (OAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data